Accelerate Diagnostics Inc reports results for the quarter ended in June - Earnings Summary

Accelerate Diagnostics

10/08/2023 22:02

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of $1.31​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of $1.40 per share.
    * Revenue fell 24.3% to $2.92 million from a year ago;
analysts
expected $3.60 million. 
    * Accelerate Diagnostics Inc's reported EPS for the quarter
was a
loss of $2.36​.
    * The mean earnings estimate of analysts had fallen by
about 12%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Accelerate Diagnostics Inc shares had fallen by 16.7% this
quarter and lost 4.4% so far this year.
    * The company reported a quarterly loss of $25.98 million.
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.40          -1.31          Beat
 Mar. 31 2023      -1.45          -1.70          Missed
 Dec. 31 2022      -1.50          -1.40          Beat
 Sep. 30 2022      -1.95          -1.80          Beat